ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline
13 juin 2022 01h00 HE
|
ImCheck Therapeutics SAS
Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trialsSeries C adds global investors Earlybird, Andera...
La tecnológica española Devo levanta una ronda de financiación de 250M de dólares liderada por TCV
26 oct. 2021 07h01 HE
|
Devo Technology
CAMBRIDGE, Mass. y MADRID, España, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Devo, empresa de seguridad y análisis de datos nativa de la nube, ha anunciado una ronda de financiación Serie E de 250M de...
Devo Announces $250 Million Funding Round Led by TCV
26 oct. 2021 07h01 HE
|
Devo Technology
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Devo Technology, the cloud-native logging and security analytics company, today announced $250 million in Series E funding at a valuation of $1.5...
Elemica Closes on Eurazeo Partnership
19 sept. 2019 08h03 HE
|
Elemica
WAYNE, Pa. and PARIS, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Elemica, the leading cloud-based Digital Supply Network for the global process Industries, today announced that it has successfully concluded...
Elemica Receives Major Investment from Eurazeo
02 août 2019 12h03 HE
|
Elemica
WAYNE, Pa. and PARIS, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Elemica, the leading cloud based Digital Supply Network for the global Process Industries, announces its acquisition by Eurazeo, a leading...